Jonathan Poole

Director

Jonathan Poole serves as Chief Financial Officer of Evelo Biosciences, Inc. a biotechnology company developing monoclonal microbials. Prior to joining Evelo, Mr. Poole was Chief Financial Officer of Genocea Biosciences Inc., a biotechnology company developing neoantigen cancer vaccines, from April 2014 to March 2018. From December 2006 to March 2014, Mr. Poole worked for Shire plc, a global biopharmaceutical company, where he was a Senior Vice President and held a number of senior roles in finance, strategic planning and portfolio management, including as leader of the finance teams supporting Shire’s global business development, R&D and technical operations activities and as divisional chief financial officer and head of strategic planning and portfolio management of Shire HGT, its rare disease division. Mr. Poole received his B.Sc in Biological Sciences from Durham University and his M.B.A. from London Business School.